Amarin and Kowa Pharmaceuticals America, Inc. Announce U.S. Co-Promotion Agreement for Vascepa® (icosapent ethyl) Capsules by longitudeadmin | Mar 31, 2014 | Portfolio News
Mallinckrodt plc Completes $1.4 Billion Acquisition of Cadence Pharmaceuticals, Inc. by longitudeadmin | Mar 19, 2014 | Portfolio News
Longitude Capital Maintains Momentum with Promotions and Team Expansion by longitudeadmin | Mar 17, 2014 | Longitude Capital News
Study Finds the Corus® CAD Gene Expression Blood Test Influenced Primary Care Decision- Making in the Assessment of Patients with Suspected Obstructive Coronary Artery Disease by longitudeadmin | Mar 10, 2014 | Portfolio News
Allergen Research Corporation Initiates Phase 2b Clinical Trial for Peanut Allergy Oral Immunotherapy (OIT) by longitudeadmin | Feb 27, 2014 | Portfolio News
